Stock UniverseDerived research view · source repositories remain read-only

Halozyme Therapeutics, Inc. (HALO)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
High
Selection Score
40.51
Global Rank
355
Market Cap
8.21B
Latest Close
71.53
RS Composite
4.69% · G#1036

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
7.81%
3M
6.17%
6M
10.62%
1Y
32.83%
3Y
120.57%
5Y
72.74%
10Y
611.03%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.14M · 30-day average: 1.79M · Max drawdown over stored range: -49.06%

Research Snapshot

Relative Strength vs SPX

RS Composite4.69%
20D RS9.09%
60D RS-1.38%
120D RS8.56%
Global RS Rank1036 · 69.12% percentile
Qualified+ RS Rank381 · 69.71% percentile
Group ScopeQualified+
Primary RS Rank114 · 75.11% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank33 / 701
Primary Percentile95.44
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2025-12-312026-02-171.40Bn/a469.01M316.89M2.561.06B10.43M1.05B124Mn/a33.58%22.69%75.88%75.13%133.82M2.14B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2025-12-31$2.5628.0x$11.286.3x$8.478.4x$8.568.4x

Shares Diluted: 124M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue443.31660.116829.2531015.3241396.611
Revenue Growth (YoY)65.665%48.906%25.622%22.438%37.553%
Gross Profit326.225454.205560.529776.8591086.347
Operating Income275.902289.431337.574551.475816.293
Free Cash Flow297.983235.3373.277468.368644.588
Free Cash Flow Per Share2.031.6732.7823.6195.202
EPS (Diluted) GAAP2.741.442.13.432.56
EPS Growth201.099%-47.445%45.833%63.333%-25.364%
EPS Non-GAAP
Gross Margin73.588%68.807%67.594%76.513%77.784%
Operating Margin62.237%43.845%40.708%54.315%58.448%
Profit Margin90.842%30.62%33.958%43.739%22.69%
Free Cash Flow Margin67.218%35.645%45.014%46.13%46.154%
Shares Outstanding (Diluted)146.796140.608134.197129.424123.904
Shares Change (YoY)3.77%-4.215%-4.559%-3.557%-4.265%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2025 Q42026-02-17451.77Mn/a-92.89M-20.56%-141.59M-31.34%-1.16122.27M133.82M2.14Bprocessed
2025 Q32025-11-03354.26Mn/a217.92M61.51%175.22M49.46%1.43122.33M419.67M800.07Mprocessed
2025 Q22025-08-05325.72Mn/a202.44M62.15%165.16M50.71%1.33124.16M61.86M1.51Bprocessed
2025 Q12025-05-06264.86Mn/a141.53M53.44%118.09M44.59%0.93126.64M176.33M1.51Bprocessed
2024 Q42025-02-18298.01Mn/a175.50M58.89%137.01M45.98%1.06129.12M115.85M1.51Bprocessed
2024 Q32024-10-31290.08Mn/a163.20M56.26%137.01M47.23%1.05130.13M154.32M1.50Bprocessed
2024 Q22024-08-06231.35Mn/a117.23M50.67%93.25M40.30%0.72129.22M187.86M1.50Bprocessed
2024 Q12024-05-07195.88Mn/a95.54M48.78%76.82M39.22%0.60128.89M164.63M1.50Bprocessed
2023 Q42024-02-20230.04Mn/a101.03M43.92%85.39M37.12%0.65131.09M118.37M1.50Bprocessed
2023 Q32023-11-06216.03Mn/a88.28M40.86%81.84M37.88%0.61134.08M274.23M1.50Bprocessed
2023 Q22023-08-08221.04Mn/a94.46M42.73%74.75M33.82%0.56133.54M221.16M1.50Bprocessed
2023 Q12023-05-09162.14Mn/a53.80M33.18%39.62M24.43%0.29137.90M96.38M1.49Bprocessed
2022 Q42023-02-21181.50Mn/a74.51M41.05%57.70M31.79%0.41139.38M234.19M1.49Bprocessed
2022 Q32022-11-08208.98Mn/a83.29M39.86%61.63M29.49%0.44139.39M147.16M1.49Bprocessed
2022 Q22022-08-09152.37Mn/a34.06M22.35%22.68M14.89%0.16142.22M90.93M1.15Bprocessed
2022 Q12022-05-10117.28Mn/a75.67M64.52%60.11M51.25%0.43141.28M117.83M788.10Mprocessed
2021 Q42022-02-22102.00Mn/a56.53M55.42%66.77M65.46%0.46144.23M118.72M787.25Mprocessed
2021 Q32021-11-02115.83Mn/a75.59M65.26%216.59M1.87%1.48146.69M491.68M786.45Mprocessed
2021 Q22021-08-09136.46Mn/a93.05M68.19%91.46M67.02%0.62147.62M446.97M785.57Mprocessed
2021 Q12021-05-1089.02Mn/a50.73M56.99%27.89M31.33%0.19148.54M499.45M784.73Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.